Nascent Biotech Officers Convert Liability to Stock in the Company
July 08, 2020 08:00 ET
|
Nascent Biotech, Inc
SAN DIEGO, July 08, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc. (OTC: NBIO) Announced today that its Senior Officers have converted the Company’s liability to them into common stock, reducing the...
Nascent Biotech Appoints Chief Medical Consultant in Charge of COVID-19 Research
June 24, 2020 08:00 ET
|
Nascent Biotech, Inc
SAN DIEGO, June 24, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc. (OTC: NBIO) announced today that it has appointed Dr. Navpaul Singh MD as Chief Medical Consultant in charge of research into...
Nascent Biotech to Begin Animal Model Studies for Pritumumab Against Coronaviruses and COVID-19
June 17, 2020 08:00 ET
|
Nascent Biotech, Inc
SAN DIEGO, June 17, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc. (OTCQB: NBIO), today announced after receiving early In-Vitro study results Pritumumab, (PTB), will be advanced to laboratory-based...
Nascent Biotech to begin Phase 1 Human Trials for Brain Cancer Drug
May 27, 2020 08:00 ET
|
Nascent Biotech, Inc
SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc (OTCQB: NBIO) (the “Company” or “Nascent”) is pleased to announce that the Company will soon begin Phase 1 clinical trials for a...
Nascent Biotech and Manhattan BioSolutions Enter into Collaboration to Advance Vaccine Discovery and Development for COVID-19
May 12, 2020 07:30 ET
|
Nascent Biotech, Inc
SAN DIEGO, May 12, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc (OTCQB: NBIO), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat cancers and viral...
Nascent Biotech Terminates Equity Line of Credit with Triton Funds
May 06, 2020 09:15 ET
|
Nascent Biotech, Inc
SAN DIEGO, May 06, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc (OTCQB: NBIO). On April 22, 2020, Nascent Biotech Inc. (the “Company”) notified Triton Funds, LLC (“Triton”) that it was...
Nascent Biotech Provides Shareholder Update on COVID-19 Therapy and Brain Cancer Trials
April 22, 2020 06:00 ET
|
Nascent Biotech, Inc
SAN DIEGO, April 22, 2020 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc., (OTCQB: NBIO) (the “Company” or “Nascent”) a leading biotechnology company developing proprietary human Monoclonal Antibodies...
Nascent Biotech to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020
April 21, 2020 10:38 ET
|
Nascent Biotech, Inc
SAN DIEGO, April 21, 2020 (GLOBE NEWSWIRE) -- Nascent, Biotech, Inc., (OTCQB: NBIO), a biotechnology company developing proprietary human Monoclonal Antibodies (mAbs) and immunotherapy for treatment...